PROM1 and colorectal cancer: Yusra and Yokozaki [178] reported that TGFBR1 and TGFBR3 were highly expressed in CD133+ colorectal cancer cells, indicating that colorectal CSCs are characterized by the activation of the TGF‐β pathway.